These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 27844089)

  • 1. [Biomarkers for dementia and other neurodegenerative diseases : Current developments].
    Wiltfang J; Lewczuk P; Otto M
    Nervenarzt; 2016 Dec; 87(12):1305-1309. PubMed ID: 27844089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinically validated molecular biomarkers of neurodegenerative dementia].
    Wiltfang J
    Nervenarzt; 2014 Nov; 85(11):1372-81. PubMed ID: 25331214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cerebrospinal fluid markers in early diagnosis of Alzheimer dementia].
    Wiltfang J
    Ther Umsch; 2015 Apr; 72(4):271-8. PubMed ID: 25791051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Novel methods for dementia diagnostics].
    Wiltfang J
    Nervenarzt; 2015 Apr; 86(4):452-60. PubMed ID: 25801947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sensitivity of neurochemical dementia diagnostics in CSF compared to 99mTc-SPECT in Alzheimer's dementia].
    Weih M; Krinninger M; Zimmermann R; Lewczuk P; Svitek J; Schaller G; Degirmenci U; Richter-Schmidinger T; Wiltfang J; Kuwert T; Kornhuber J; Schmidt D
    Fortschr Neurol Psychiatr; 2009 Jul; 77(7):407-11. PubMed ID: 19582652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal IgG synthesis in patients with alterations in the neurochemical dementia diagnostics.
    Zimmermann R; Beck G; Knispel S; Maler JM; Weih M; Wiltfang J; Kornhuber J; Lewczuk P
    J Alzheimers Dis; 2010; 19(4):1199-203. PubMed ID: 20308786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How many biomarkers to discriminate neurodegenerative dementia?
    Sancesario GM; Bernardini S
    Crit Rev Clin Lab Sci; 2015; 52(6):314-26. PubMed ID: 26292074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-β Isoforms for Early and Differential Dementia Diagnosis.
    Struyfs H; Van Broeck B; Timmers M; Fransen E; Sleegers K; Van Broeckhoven C; De Deyn PP; Streffer JR; Mercken M; Engelborghs S
    J Alzheimers Dis; 2015; 45(3):813-22. PubMed ID: 25633670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases.
    Otto M; Lewczuk P; Wiltfang J
    Methods; 2008 Apr; 44(4):289-98. PubMed ID: 18374272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current application of neurochemical biomarkers in the prediction and differential diagnosis of Alzheimer's disease and other neurodegenerative dementias.
    Genius J; Klafki H; Benninghoff J; Esselmann H; Wiltfang J
    Eur Arch Psychiatry Clin Neurosci; 2012 Nov; 262 Suppl 2():S71-7. PubMed ID: 22986448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical indications for analysis of Alzheimer's disease CSF biomarkers.
    Engelborghs S
    Rev Neurol (Paris); 2013 Oct; 169(10):709-14. PubMed ID: 24016466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurochemical dementia diagnostics: State of the art and research perspectives.
    Lewczuk P; Wiltfang J
    Proteomics; 2008 Mar; 8(6):1292-301. PubMed ID: 18271068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cerebrospinal fluid biomarkers to predict conversion to dementia in patients with mild cognitive impairment: a clinical cohort study.
    Tondelli M; Bedin R; Chiari A; Molinari MA; Bonifacio G; Lelli N; Trenti T; Nichelli P
    Clin Chem Lab Med; 2015 Feb; 53(3):453-60. PubMed ID: 25274948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
    Li QX; Villemagne VL; Doecke JD; Rembach A; Sarros S; Varghese S; McGlade A; Laughton KM; Pertile KK; Fowler CJ; Rumble RL; Trounson BO; Taddei K; Rainey-Smith SR; Laws SM; Robertson JS; Evered LA; Silbert B; Ellis KA; Rowe CC; Macaulay SL; Darby D; Martins RN; Ames D; Masters CL; Collins S;
    J Alzheimers Dis; 2015; 48(1):175-87. PubMed ID: 26401938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study.
    Lewczuk P; Kamrowski-Kruck H; Peters O; Heuser I; Jessen F; Popp J; Bürger K; Hampel H; Frölich L; Wolf S; Prinz B; Jahn H; Luckhaus Ch; Perneczky R; Hüll M; Schröder J; Kessler H; Pantel J; Gertz HJ; Klafki HW; Kölsch H; Reulbach U; Esselmann H; Maler JM; Bibl M; Kornhuber J; Wiltfang J
    Mol Psychiatry; 2010 Feb; 15(2):138-45. PubMed ID: 18663368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.
    Hall S; Öhrfelt A; Constantinescu R; Andreasson U; Surova Y; Bostrom F; Nilsson C; Håkan W; Decraemer H; Någga K; Minthon L; Londos E; Vanmechelen E; Holmberg B; Zetterberg H; Blennow K; Hansson O
    Arch Neurol; 2012 Nov; 69(11):1445-52. PubMed ID: 22925882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of neuropsychological testing, imaging, and CSF biomarkers for the differential diagnosis and prognosis of clinically ambiguous dementia.
    Boutoleau-Bretonnière C; Lebouvier T; Delaroche O; Lamy E; Evrard C; Charriau T; Bretonnière C; Damier P; Derkinderen P; Vercelletto M
    J Alzheimers Dis; 2012; 28(2):323-36. PubMed ID: 22008265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurochemical dementia diagnostics: a simple algorithm for interpretation of the CSF biomarkers.
    Lewczuk P; Zimmermann R; Wiltfang J; Kornhuber J
    J Neural Transm (Vienna); 2009 Sep; 116(9):1163-7. PubMed ID: 19653063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.